These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8234994)

  • 21. Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction.
    Fujita M; Asanuma H; Kim J; Liao Y; Hirata A; Tsukamoto O; Minamino T; Hori M; Goto M; Node K; Kitakaze M
    Int J Cardiol; 2007 May; 118(1):76-80. PubMed ID: 16934350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
    Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
    Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concept of cardiovascular remodeling and cardioreparation.
    Birbari AE
    J Med Liban; 1994; 42(1):16. PubMed ID: 7629830
    [No Abstract]   [Full Text] [Related]  

  • 24. Origin and mechanisms of heart failure in hypertensive patients: left ventricular remodelling in hypertensive heart disease.
    Dubus I; Samuel JL; Swynghedauw B
    Eur Heart J; 1993 Nov; 14 Suppl J():76-81. PubMed ID: 8281969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different involvement of right ventricular myocardial function in either physiologic or pathologic left ventricular hypertrophy: a Doppler tissue study.
    D'Andrea A; Caso P; Severino S; Sarubbi B; Forni A; Cice G; Esposito N; Scherillo M; Cotrufo M; Calabrò R
    J Am Soc Echocardiogr; 2003 Feb; 16(2):154-61. PubMed ID: 12574742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S; Volpe M; Raman V; Lindpaintner K
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
    Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
    Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Can left ventricular pathological hypertrophy in arterial hypertension be distinguished from physiological hypertrophy due to sports?].
    Franz IW
    Dtsch Med Wochenschr; 2002 Feb; 127(5):225-6; author reply 226-7. PubMed ID: 11822001
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophy.
    Rosei EA
    Blood Press; 2003; 12(3):183-4. PubMed ID: 12875482
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular mass, diastolic dysfunction, and hypertension.
    Gottdiener JS
    Adv Intern Med; 1993; 38():31-56. PubMed ID: 8438643
    [No Abstract]   [Full Text] [Related]  

  • 33. Physical activity in the prevention and management of high blood pressure.
    Kokkinos PF; Giannelou A; Manolis A; Pittaras A
    Hellenic J Cardiol; 2009; 50(1):52-9. PubMed ID: 19196621
    [No Abstract]   [Full Text] [Related]  

  • 34. Respective impacts of aortic stenosis and systemic hypertension on left ventricular hypertrophy.
    Garcia D; Pibarot P; Kadem L; Durand LG
    J Biomech; 2007; 40(5):972-80. PubMed ID: 16750211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?
    Borer JS
    J Am Coll Cardiol; 2004 Jul; 44(2):406-8. PubMed ID: 15261939
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension and the heart.
    Mancia G; Scopelliti F; Grassi G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):198-202. PubMed ID: 16959750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of ventricular arrhythmias in the presence of pathological hypertrophy.
    Cosín Aguilar J; Hernandiz Martinez A; Andres Conejos F
    Eur Heart J; 1993 Nov; 14 Suppl J():65-70. PubMed ID: 8281966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The concept of left ventricular hypertrophy: the frontiers between physiology and pathology].
    Zarco P
    Rev Esp Cardiol; 1993 Oct; 46(10):607-15. PubMed ID: 8234994
    [No Abstract]   [Full Text] [Related]  

  • 40. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease.
    Strauer BE; Schwartzkopff B
    Blood Press Suppl; 1997; 2():6-12. PubMed ID: 9495619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.